...
首页> 外文期刊>CVIR Endovascular >Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report
【24h】

Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report

机译:沉淀疏水可注射液(PHIL)栓塞治疗子宫动脉畸形:技术报告

获取原文
           

摘要

ObjectiveUterine arteriovenous malformations (AVM) are unusual causes of vaginal bleeding. Although hysterectomy is the definitive treatment; uterine artery embolization (UAE) provides an alternative therapeutic option. This case presents a technical report of a uterine AVM treated successfully with transcatheter UAE using precipitating hydrophobic injectable liquid (PHIL) embolic agent.Case reportA 41-year-old female, gravida 6, para 4, miscarriage 2, including a molar pregnancy 15?years prior, presented with massive per vaginal bleeding. Pelvic ultrasound demonstrated an acquired AVM as the underlying aetiology for her presentation. The patient underwent bilateral uterine arterial embolization. Four weeks later, there was nearly complete resolution of the AVM and the patient’s menstrual cycle was restored 8?weeks after the procedure.ConclusionUterine AVM can be treated safely and effectively with UAE using PHIL.
机译:ObiorIforterine动脉畸形(AVM)是阴道出血的不寻常原因。虽然子宫切除术是最终的治疗;子宫动脉栓塞(阿联酋)提供替代治疗选择。本病例呈现了用经截管阿联酋的子宫抗体治疗的子宫AVM的技术报告,使用沉淀疏水性注射液(PHIL)栓塞剂。Case exporta 41岁女性,Gravida 6,第4段,流产2,包括摩尔妊娠15?年前,呈每阴道出血大规模呈现。骨盆超声证明了被收购的AVM作为她的介绍的潜在的缓解学。患者接受双侧子宫动脉栓塞。四周后,有几乎完全分辨率的AVM,患者的月经周期已经恢复了8?手术后的周数。可以使用Phil安全有效地治疗抵制菲尔治疗途径AVM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号